Dictionary

allow_url_fopen is ENABLED Dictionary Search

osteosarcoma

Synonyms

Noun

1. osteogenic sarcoma

2. sarcoma

Usage
Potential Applications for Tumor-Informed ctDNA Deep Sequencing in Osteosarcoma - OncLive
Osteosarcoma in a Young Patient: When the Tumor Reaches the Heart - JACC Journals
Giving CAR T a second life in osteosarcoma - Fred Hutchinson Cancer Center
Innovations That Are Transforming Osteosarcoma Outcomes - Cleveland Clinic
Blood-based DNA signals may help track osteosarcoma in children - UChicago Medicine
FDA Grants ODD to LRRC15-Targeting ADC SOT106 for Osteosarcoma - Targeted Oncology
A New Method for Stopping Osteosarcoma from Spreading to the Lungs - CU Anschutz newsroom
The first limb-sparing use of histotripsy for canine osteosarcoma - Nature
New research offers hope for osteosarcoma patients - American Animal Hospital Association - AAHA
Advances in T cell–based immunotherapy for osteosarcoma - Frontiers
Finding Better Answers for Patients With a Deadly Bone Cancer - Tufts Now
Dr Randall on the Clinical Utility of Tumor-Informed ctDNA Deep Sequencing for Osteosarcoma Surveillance - OncLive
Decoding CTCs in osteosarcoma: the molecular journey from initial tumor to metastasis | Scientific Reports - Nature
Case Report: Feline spinous process giant-cell osteosarcoma - Frontiers
Vitamin D receptor (VDR) expression in osteosarcoma and its association with histological subtypes and metastasis - Nature
sB7-H3 as a prognostic biomarker in osteosarcoma: insights into clinical outcomes | Scientific Reports - Nature
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial - Nature
Dynamic assessment of a humanized bone tumour microenvironment reveals insights into osteosarcoma primary tumour remodelling and lung metastases | Scientific Reports - Nature
SHP2 promotes osteosarcoma via regulating STAT3/TET3/HOXB2 signaling - Nature
Histological prognostic factors in canine appendicular osteosarcoma: 57 cases (2014–2022) - Nature
Functional personalized complex combination nano therapy for osteosarcoma | Scientific Reports - Nature
FDA Grants RPDD and ODD to FL118 for Osteosarcoma - Targeted Oncology
Osteosarcoma of the appendicular skeleton in dogs: consensus and guidelines - Frontiers
Case Report: Osteosarcoma following traumatic injury in a juvenile Argentine black and white tegu ( Salvator merianae - Frontiers
Osteosarcoma: Leading-Edge Insights and Personalized Care - University of Miami
Involvement of TP53 in osteosarcoma - challenges and prospects - Frontiers
Chemo-Nonresponsive Telangiectatic Osteosarcoma With Oligometastatic Recurrence Managed With Multimodality Therapy Including Stereotactic Ablative Body Radiotherapy (SABR): A Case Report With a Pathologic Treatment Effect - Cureus
Daily Dose - Former College Athlete Faces Osteosarcoma With Faith, Fitness and a Goal To Walk Again - Atrium Health
Osteosarcoma Drug Earns Rare Pediatric Disease, Orphan Drug Designations - CancerNetwork
Molecular guided therapy leading to exceptional response in relapsed osteosarcoma - Frontiers
Multi-Target OSM CAR T Shows Activity Against Osteosarcoma in Preclinical Models - Inside Precision Medicine
New PET imaging platform improves osteosarcoma surgery precision - News-Medical
HDACi induces apoptosis of osteosarcoma cells by inhibiting the MAPK pathway - Nature
The clinical trial landscape of osteosarcoma: integrating trial data, immunotherapeutic trends, and biomarker insights - Frontiers
Researchers develop promising new therapy for most common form of bone cancer in children and young adults - Case Western Reserve University
Personalized mRNA vaccine targets osteosarcoma relapse in first human use - Medical Xpress
SMARCAL1 Identified as a Predisposition Gene for Osteosarcoma - Cleveland Clinic
Orbital Exenteration in Maxillary Osteosarcoma: A Case Report - Cureus
Cancer therapy meeting key safety checkpoints in human trial - Colorado State University
Masquerade ball gives cancer survivors an evening to remember - WSYX
Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, in Relapsed/Refractory Osteosarcoma - PR Newswire
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma | Oncogene - Nature
Tufts' Cummings School joins Break Through Cancer's Defying Osteosarcoma | Vet Candy Veterinary News - Vet Candy
Therapeutic efficacy of oncolytic adenovirus YSCH-01 in osteosarcoma evaluated in PDX and CDX mouse models - Nature
ZDHHC9 promotes osteosarcoma progression via KRAS-associated enhancement of the RAS/MAPK signaling pathway - Nature
Study reveals new dual role of ezrin in osteosarcoma - News-Medical
LRRC15 shows promise as a pediatric osteosarcoma immunotherapy target - St. Jude Children's Research Hospital
Restoring ADAR2 enzyme reduces metastatic spread in osteosarcoma - News-Medical
Green Level High students' RadiAid app uses AI to detect osteosarcoma, advancing to national finals - WRAL
New Research Reveals Genetic Link to Most Common Pediatric Bone Cancer - Cleveland Clinic Newsroom
Primary Parosteal Osteosarcoma of the Bone With Rhabdomyosarcomatous Features: A Rare Bone Tumour With a Pathological Dilemma - Cureus
After cancer battle, CNE's Lucas Yeager found strength beyond sports - Cincinnati Enquirer
New therapy combines imaging and targeted radiation to treat aggressive bone cancer - UCLA Health
Sotio Biotech’s SOT-106 designated orphan drug for osteosarcoma - BioWorld News
Unveiling the role of the extracellular matrix in the osteosarcoma tumor microenvironment through integrated transcriptomics and experimental validation - Nature
Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth - Johns Hopkins Medicine
Immune exclusion as a recurrent immune-escape state driving treatment resistance in osteosarcoma: insights from single-cell, spatial, and multi-omics studies - Frontiers
FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma - Roswell Park Comprehensive Cancer Center
OS Therapies eyes global osteosarcoma vaccine approvals after Phase IIb win - Clinical Trials Arena
Finding Better Answers for Patients with a Deadly Bone Cancer | Newswise - Newswise
OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World - TMX Newsfile
ENO1 promotes cancer metastasis via stimulating metabolism reprogramming in osteosarcoma - Nature
12-year-old Clarence boy battling Osteosarcoma receives room makeover - WGRZ
Osteosarcoma immunometabolism: emerging mechanisms and clinical implications - Frontiers
From the Lab to the Clinic: Exploring DFMO’s Potential to Prevent Metastatic Disease in Children With Osteosarcoma and Ewing Sarcoma - OncLive
Aberrant EZHIP expression drives tumorigenesis in osteosarcoma - Nature
Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights - Frontiers
OST-HER2 Displays Potential OS Benefit in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma - OncLive
In osteosarcoma trial, OST-HER2 hits 75% 2.5-year survival vs 47% - Stock Titan
BLA Submission to FDA Underway for Metastatic Osteosarcoma Treatment - CancerNetwork
Denosumab Displays Tolerability, Combination Potential in AYA Osteosarcoma - OncLive
Clinical and tissue evidence of immune dysregulation in osteosarcoma: altered peripheral neutrophil-related indices and reduced APOE expression - Frontiers
Engineering Osteosarcoma In Vitro: From Traditional Models to Biofabricated Platforms for Precision Medicine - ACS Publications
Novel niclosamide prodrug shows promise against canine osteosarcoma - DVM360
Bone Cancer Treatment Market Size, Share | Growth [2034] - Fortune Business Insights
‘A big deal’: Discovery of new genetic link to osteosarcoma opens ‘window of opportunity’ - Healio
OS Therapies Provides Global Regulatory Update for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metstatic Osteosarcoma - TMX Newsfile
OST-HER2 Immunotherapy Demonstrates Statistically Significant 2-Year Overall Survival Benefit in Patients with Fully Resected Pulmonary Metastatic Osteosarcoma - Vera Health
OS Therapies Achieves Global Regulatory Alignment on Design of Phase 3 Trial of OST-HER2 in Fully Resected, Pulmonary Metastatic Osteosarcoma - TMX Newsfile
Dogs with cancer are helping save lives—both canine and human - Penn Today
Rolling FDA BLA Submission for OST-HER2 Begins for Fully Resected Pulmonary Metastatic Osteosarcoma - OncLive
Mifamurtide Plus Chemotherapy for Nonmetastatic High-Grade Osteosarcoma - The ASCO Post
Pediatric Neuroblastoma and Osteosarcoma Survivor Charts Course to Medical School - Dana-Farber Cancer Institute
SPON2 facilitates osteosarcoma development by inducing M2 macrophage polarization through activation of the NF-κB/VEGF signaling axis - Nature
Lamins' role in osteosarcoma - Frontiers
Evaluating the synergistic effects of cisplatin and tamoxifen in canine osteosarcoma cells - Frontiers
New Bone Research Gives Hope to Kids and Dogs With Osteosarcoma - UC Davis
Two pediatric cancer patients become close friends during treatment - michiganmedicine.org
OS Therapies Achieves Statistically Significant 2.5-Year Overall Survival in Phase 2b Trial of OST-HER2 in Fully Resected Pulmonary Metastatic Osteosarcoma - TMX Newsfile
Gene Discovery Sheds Light on Osteosarcoma Risk in Children - Inside Precision Medicine
Research Reveals Genetic Link to Most Common Pediatric Bone Cancer - Cleveland Clinic Newsroom
Single-Cell Dissection of PTM-Related Networks Reveals an Immunosuppressed Osteosarcoma Ecosystem - Frontiers
Osteosarcoma in Dogs: What You Need to Know About This Aggressive Cancer - Daily Paws
Studies link SMARCAL1 to increased risk for pediatric bone cancer - St. Jude Children's Research Hospital
HSP90AB1-Mediated Ubiquitin-Proteasome Degradation of ITGBL1 Promotes Osteosarcoma Progression by Inhibiting Endoplasmic Reticulum Stress-Induced Autophagy - Wiley
Case Report: Primary extraskeletal osteosarcoma in prostate - Frontiers
Surviving osteosarcoma: Jamaican cancer survivor shares story of faith and resilience in new memoir - Caribbean National Weekly
Comparative Outcomes of Limb Salvage Surgery Versus Amputation in Osteosarcoma: A Five-Year Follow-Up Study From a Tertiary Care Center - Cureus
SOCS1 depletion drives osteosarcoma stemness and chemoresistance by suppressing ACTN4 degradation - Nature
OS Therapies Granted EMA's Advanced Therapy Medicinal Product (ATMP) Designation for OST-HER2 in the Treatment of Pulmonary Recurrence in Resected Osteosarcoma - TMX Newsfile
Foreign Language Equivalents
Foreign Language Equivalents of 'osteosarcoma'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
osteoaarcoma,   osteosaroma,   osteosracoma,   osteosrcoma,   osteosarcpma,   ostrosarcoma,   ossteosarcoma,   oseosarcoma,   osteosacroma,   ostteosarcoma,   oteosarcoma,   osteeosarcoma,   osteosarcoam,   osteosarcomma,   osreosarcoma,   osteisarcoma,   osteosacoma,   osteosarcona,   osteosarcima,   osteosarcma,   osteoasrcoma,   osteoarcoma,   ostosarcoma,   osyeosarcoma,   osteosaarcoma,   soteosarcoma,   psteosarcoma,   otseosarcoma,   osteosaecoma,   osteossrcoma,   osteossarcoma,   oosteosarcoma,   osteodarcoma,   osteosarco,a,   osteosarcoms,   oateosarcoma,   osteosarxoma,   ostepsarcoma,   osteosarcom,   osteosarcmoa,   odteosarcoma,   osteosarrcoma,   osteosatcoma,   ostesarcoma,   osteoosarcoma,   steosarcoma,   osteosarvoma,   ostwosarcoma,   osteosarcooma,   osteosarocma,   ostesoarcoma,   isteosarcoma,   ostoesarcoma,   osetosarcoma,   osteosarcoa,   osteosarcomaa,   osteosarccoma
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z